CA2271930A1 - Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof - Google Patents

Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof Download PDF

Info

Publication number
CA2271930A1
CA2271930A1 CA002271930A CA2271930A CA2271930A1 CA 2271930 A1 CA2271930 A1 CA 2271930A1 CA 002271930 A CA002271930 A CA 002271930A CA 2271930 A CA2271930 A CA 2271930A CA 2271930 A1 CA2271930 A1 CA 2271930A1
Authority
CA
Canada
Prior art keywords
strain
lactobacillus acidophilus
ferment
particular strain
strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002271930A
Other languages
French (fr)
Other versions
CA2271930C (en
Inventor
Francois-Marie Luquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio K Plus International Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2271930A1 publication Critical patent/CA2271930A1/en
Application granted granted Critical
Publication of CA2271930C publication Critical patent/CA2271930C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Abstract

The purified strain of Lactobacillus acidophilus CNCM/I-1492 (L.a. 1492) when administered alone or in combination with another Lactobacillus acidophilus (L.a.) strain and Lactobacillus casei (L.c.) strain, has a beneficial effect on the cholesterol blood level in mammals.
It also strenghtens the immune system, facilitates the absorption of nutrients and stimulates the intestinal flora. Such strains also neutralize side effects caused by antibiotics. The invention concerns the specific strain L.a. I-1492, a ferment comprising L.a. I-1492, L.a. and L.c.
strains, a dairy product obtained by this ferment and a method of manufacturing the dairy product.
CA002271930A 1996-11-29 1997-11-28 Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof Expired - Lifetime CA2271930C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3215796P 1996-11-29 1996-11-29
US60/032,157 1996-11-29
PCT/CA1997/000915 WO1998023727A1 (en) 1996-11-29 1997-11-28 Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof

Publications (2)

Publication Number Publication Date
CA2271930A1 true CA2271930A1 (en) 1998-06-04
CA2271930C CA2271930C (en) 2006-10-17

Family

ID=21863414

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002271930A Expired - Lifetime CA2271930C (en) 1996-11-29 1997-11-28 Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof

Country Status (8)

Country Link
US (1) US6607905B1 (en)
EP (2) EP2159277A1 (en)
AT (1) ATE355360T1 (en)
AU (1) AU5113798A (en)
CA (1) CA2271930C (en)
DE (1) DE69737420T2 (en)
ES (1) ES2283027T3 (en)
WO (1) WO1998023727A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
SK283008B6 (en) * 1997-08-21 2003-01-09 New Zealand Dairy Board Biologically pure culture Lactobacillus rhamnosus, composition containing it and use
ATE290391T1 (en) * 1998-12-11 2005-03-15 Urex Biotech Inc ORAL ADMINISTRATION OF LACTOBACILLUS FOR THE TREATMENT AND PREVENTION OF UROGENITAL INFECTIONS
AU5069500A (en) * 1999-05-07 2000-11-21 Compagnie Gervais Danone Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
ES2155783B1 (en) * 1999-05-07 2002-05-16 Danone Sa NEW USE OF LACTOBACILLUS CASEI FOR THE PREPARATION OF FERMENTED MILKS FOR THE TREATMENT OF DEPRESSED IMMUNE LEVELS.
ES2155782B1 (en) * 1999-05-07 2002-05-16 Danone Sa USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.
CA2374937A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
WO2000071139A2 (en) * 1999-05-25 2000-11-30 Gregor Reid Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
WO2001097821A1 (en) * 2000-06-19 2001-12-27 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
ES2169675B1 (en) * 2000-07-19 2003-04-16 Danone Sa PRODUCT WITH ANTI-INFLAMMATORY PROPERTIES FOR THE HUMAN COLON.
CA2364249A1 (en) 2001-11-27 2003-05-27 Unknown-Inconnu Effect of lactic bacteria on tumour cell death
DK1485463T3 (en) 2002-03-21 2008-11-10 Bifodan As Lactobacillus strain
CN1317385C (en) * 2003-05-30 2007-05-23 上海光明乳业股份有限公司 Cheese lactobacillus Bd-II strain and use for decreasing blood fat
CA2448843A1 (en) * 2003-11-13 2005-05-13 Bio-K Plus International Inc. Effects of different supernatants of bio-k plus lactic acid bacteria on endothelial cell lines
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
CA2470090A1 (en) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Lactic bacteria and their uses in preventing diarrhea associated with antibiotics
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
US20110165127A1 (en) * 2006-06-09 2011-07-07 Fabiola Masri Dairy-derived probiotic compositions and uses thereof
AU2013201783B2 (en) * 2006-10-02 2015-06-04 Dupont Nutrition Biosciences Aps Probiotics for use in reducing the incidence and duration of illness
BRPI0719787A2 (en) * 2006-10-02 2014-11-25 Danisco PROBIOTICS FOR USE IN REDUCING NURSING INCIDENCE AND DURATION
MX2009006810A (en) * 2006-12-22 2009-11-23 Francois-Marie Luquet Growth inhibition of microorganisms by lactic acid bacteria.
ATE526027T1 (en) * 2006-12-22 2011-10-15 Bio K Plus Internat Inc GROWTH INHIBITION AND ELIMINATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BY LACTIC ACID BACTERIA
PL2124966T3 (en) 2007-02-01 2016-01-29 Iams Europe B V Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
CN101250493B (en) * 2008-04-01 2010-06-02 浙江省农业科学院 Method for producing feeding lactobacillus acidophilus by solid-liquid two-step fermentation technique
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CL2009001511A1 (en) * 2009-07-02 2009-10-23 Univ De Concepcion 61 02% Pharmaceutical formulation comprising viable strains of lactobacillus acidophilus lpv 31 and l. plantarum lpm-01, which is useful in the prevention and / or treatment of urinary infections and in improving the immune response in immunocompromised patients.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CA2915979C (en) 2013-06-27 2021-06-08 Starbucks Corporation D/B/A Starbucks Coffee Company Biopreservation methods for beverages and other foods
AT517321A1 (en) * 2015-06-10 2016-12-15 Trodat Gmbh stamp
WO2023066973A1 (en) * 2021-10-19 2023-04-27 Kerry Group Services International Limited Probiotic strains for reducing blood cholesterol and/or treating dyslipidemia, and methods for using and producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109729A (en) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd Cholesterol lowering agent
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
ES2111625T3 (en) * 1992-07-06 1998-03-16 Nestle Sa ANTIGASTRITIS AGENT.
DK0577904T3 (en) * 1992-07-06 1997-10-27 Nestle Sa The lactic acid bacteria.
JP2992945B2 (en) * 1994-03-11 1999-12-20 カルピス株式会社 Lactobacillus acidophilus lactic acid bacteria

Also Published As

Publication number Publication date
DE69737420T2 (en) 2007-11-15
US6607905B1 (en) 2003-08-19
WO1998023727A1 (en) 1998-06-04
ES2283027T3 (en) 2007-10-16
EP0951531B1 (en) 2007-02-28
EP2159277A1 (en) 2010-03-03
AU5113798A (en) 1998-06-22
DE69737420D1 (en) 2007-04-12
CA2271930C (en) 2006-10-17
ATE355360T1 (en) 2006-03-15
EP0951531A1 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
CA2271930A1 (en) Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
GB2338245A (en) Immunity enhancing lactic acid bacteria
GB2134133B (en) A process for the manufacture of a naturally carbonated beverage
EP1011721A4 (en) Vaginal lactobacillus medicant
WO2000072855A3 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
CA2091557A1 (en) Intestine colonizing lactobacilli
CA2216150A1 (en) Epithelial adhesive lactobacilli
AU4158793A (en) Lactic acid bacterium
CA2333205A1 (en) A beneficial microbe composition, new protective materials for the microbes, the method to prepare and uses thereof
WO2003033681A3 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
HUP0003744A3 (en) Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same
EP0861905A3 (en) Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
WO1999061627A3 (en) Mutant lactobacillus bulgaricus strains free from beta-galactoside activity
AU6882094A (en) Lactobacillus bulgaricus having decreased acid production and/or improved aroma and flavor production, and food composition comprising said lactobacillus bulgaricus
EP0652285A3 (en) Lactic acid bacteria and fermented milk product.
AU3161801A (en) Somnogenic activity of non-pathogenic lactic acid bacteria
ZA969111B (en) Lactic ferments and their use for the production of hypocholesterolaemic products.
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
GB2228494A (en) Method of obtaining a bacterial ferment for medical-dietetic product
AU7186191A (en) Lactobacillus acidophilus F-133, lactic acid bacterium preparation prepared therefrom, and process for preparing the same
KR960009494B1 (en) Processing of soybean fermemented milk by using isolated soybean protein and carbohydrate
BG103015A (en) Dietetic lactic acid products for food therapy and ferments for lactic acid products
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
UA41491C2 (en) Healthful and dietary fermented milk product
ES2155783A1 (en) Lactic acid bacteria used in the preparation of orally-administrable fermented milks for the treatment of temporarily-depressed immunity levels in individuals subjected to physiological stress

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20171128